Last updated on December 2019

Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome


Brief description of study

This study will assess the potential impact of Elagolix on disordered pituitary and ovarian hormones in women with Polycystic Ovary Syndrome (PCOS).

Detailed Study Description

This is a Phase 2, multicenter, double-blind (sponsor-unblinded), randomized, placebo-controlled study to assess the safety and efficacy of Elagolix in women with polycystic ovary syndrome (PCOS). PCOS is one of the most common hormonal disorders in women of reproductive age, yet few treatment options are available. This study will help determine if Elagolix can impact disordered hormonal dynamics in women with PCOS and at what dosage.

Clinical Study Identifier: NCT03951077

Find a site near you

Start Over

Asr, Llc /Id# 207037

Nampa, ID United States
  Connect »

Univ Hosp Landerbrook /ID# 205558

Mayfield Heights, OH United States
  Connect »